Work

MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition In vivo

Year: 2010

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-10-0582

Authors: Rakesh K. Srivastava, Razelle Kurzrock, Sharmila Shankar

Institutions: The University of Texas MD Anderson Cancer Center, The University of Kansas Cancer Center, University of Kansas Medical Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Susan G. Komen for the Cure, Susan G. Komen

OpenAlex ID: W2160641961

FWCI: 4.947

Cites: 57

Cited by: 131

Related to: 10